NDC 0378-0197-05
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0197
- Requested NDC
- 0378-0197-05
- Package NDCs from labels
- 0378-0197-05
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0197-01 | EA - Each | 0378-0197 | 705c1658-2999-4e88-b00b-270645844035 | 1 | 2012-07-24 |
| 0378-0197-05 | EA - Each | 0378-0197 | 4ae28794-a74e-4ae7-bbf0-2fa45be72791 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pregabalin | PREGABALIN | Mylan Pharmaceuticals Inc. | ebe34db4-816d-4f0a-adbb-826693662754 | 2025-04-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Levetiracetam | LEVETIRACETAM | Mylan Pharmaceuticals Inc. | 0a987d59-560f-4650-96ec-31aec81953b5 | 2025-04-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| GABAPENTIN | GABAPENTIN | Mylan Pharmaceuticals Inc. | cff7de45-148b-4e96-88fd-6052bf75b5f7 | 2025-04-12 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| ILOPERIDONE | ILOPERIDONE | Mylan Pharmaceuticals Inc. | eeb0fcfd-e4e8-4fb1-9635-901dc9446235 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Saxagliptin | SAXAGLIPTIN | Mylan Pharmaceuticals Inc. | 6e8d8c4f-96eb-4b64-9c8c-4a5448a23a78 | 2025-02-28 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Alprazolam XR | ALPRAZOLAM | Mylan Pharmaceuticals Inc. | 1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Glatiramer Acetate | GLATIRAMER ACETATE | Mylan Pharmaceuticals Inc. | f38b5606-d2d7-44ec-912f-46882aa2fa7b | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Glatiramer Acetate | GLATIRAMER | Mylan Pharmaceuticals Inc. | 456a34c7-8511-4000-99a7-ad8f8de6d35e | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Alprazolam | ALPRAZOLAM | Mylan Pharmaceuticals Inc. | 13930c94-d83a-414f-be35-b1fef35f738d | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Haloperidol | HALOPERIDOL | Mylan Pharmaceuticals Inc. | c559b0b0-4087-d12a-e718-c18ccb6811e6 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Thioridazine Hydrochloride | THIORIDAZINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 56b3f4c2-52af-4947-b225-6808ae9f26f5 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Trifluoperazine Hydrochloride | TRIFLUOPERAZINE HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | c2575a86-19e5-44df-8603-ff066bb9c9c5 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Phenytoin | PHENYTOIN | Mylan Pharmaceuticals Inc. | 37943ec1-a8d2-42df-967e-6f96f84c017b | 2024-12-24 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Azelastine Hydrochloride and Fluticasone Propionate | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | Mylan Pharmaceuticals Inc. | 7b5cc5a0-0d47-46b5-b5fb-eb9cc248ae9e | 2024-12-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Glucagon | GLUCAGON | Mylan Pharmaceuticals Inc. | 15b49500-0aae-4e25-9a1d-709983233cc6 | 2024-12-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate | EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE | Mylan Pharmaceuticals Inc. | d9a4185e-43fa-4aeb-9b0f-8db01b166038 | 2024-12-14 | Boxed warning, Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| amlodipine besylate | AMLODIPINE BESYLATE | Mylan Pharmaceuticals Inc. | 180ee374-24f2-4b9c-9d54-8815f2b1dc9b | 2024-11-28 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Budesonide | BUDESONIDE | Mylan Pharmaceuticals Inc. | f7265276-e649-4bc4-8ac8-1f5ac2b984e8 | 2024-11-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| Amlodipine and atorvastatin | AMLODIPINE AND ATORVASTATIN | Mylan Pharmaceuticals Inc. | 4be76756-4114-4d50-a36c-fd410f6c773d | 2024-11-11 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
| NITROGLYCERIN | NITROGLYCERIN | Mylan Pharmaceuticals Inc. | 041f127e-5166-4484-bc1a-0a373d1187ae | 2024-10-15 | Warnings, Adverse reactions | Mylan Pharmaceuticals Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.